Bookmark Saya

CrossRef 2016

O51 Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to <sc>cs</sc>Dmards: Summary Results from the 24-Week Phase III RA-Build Study

Lihat Sumber DOI

Format Sitasi

APA MLA BibTeX
(2016). O51 Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to <sc>cs</sc>Dmards: Summary Results from the 24-Week Phase III RA-Build Study. https://doi.org/10.1093/rheumatology/kew121.002

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.1093/rheumatology/kew121.002
Informasi Jurnal
Tahun Terbit
2016
Bahasa
en
Sumber Database
CrossRef
DOI
10.1093/rheumatology/kew121.002
Akses
Terbatas